TSX News -
Dorel Industries Inc. Announces Annual Meeting of Shareholders
MONTREAL, June 03, 2020 (GLOBE NEWSWIRE) —Wednesday, June 10, 2020 at 10:00 A.M.In light of the COVID-19 pandemic, shareholders are […]
TSX News -
REMINDER – KP Tissue Announces its Annual Meeting of Shareholders
MISSISSAUGA, Ontario, June 03, 2020 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT”) (TSX: KPT) will hold its Annual Meeting of […]
Gold as Safe-Haven Asset—Why Mining Companies are Anticipating Upcoming Boom
New York, June 03, 2020 (GLOBE NEWSWIRE) — via NetworkWire — Kingman Minerals Ltd. (CVE: KGS) today announces its placement […]
Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus
SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients […]
TSX News -
Sabina Gold & Silver Announces $55 Million Bought Deal Financing Closed
Not for distribution to U.S. news wire services or dissemination in the United StatesVANCOUVER, British Columbia, June 03, 2020 (GLOBE […]
Cassava Sciences Announces Presentation at the Jefferies Virtual Healthcare Conference and Provides Updates Regarding Phase 2b Study of PTI-125
– High Variability in Levels of Biomarkers in Control Arm of Phase 2b Study May Drive Reassessment of Overall Study […]
Outlook Therapeutics Announces Closing of $16.0 Million Private Placement
MONMOUTH JUNCTION, N.J., June 03, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the Company), a late clinical-stage biopharmaceutical company working to […]
Trevena Announces Advancement of Oliceridine Clinical Development in China by Jiangsu Nhwa Pharmaceutical Co.
CHESTERBROOK, Pa., June 03, 2020 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and […]
Allakos Initiates Patient Recruitment for AK002 Registrational Studies
— Phase 3 study in eosinophilic gastritis and/or eosinophilic duodenitis and Phase 2/3 study in eosinophilic esophagitis — — Top-line safety […]
BeyondSpring Announces Data & Safety Monitoring Board Recommendation for Plinabulin to Continue NSCLC Phase 3 Dublin-3 Study Without Modification
– DSMB Reviewed Over 500 Patients’ Data in Second Interim Analysis to Assess Overall Benefit / Risk with Plinabulin in […]
